U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024.

  • This publication is provided for historical reference only and the information may be out of date.

This publication is provided for historical reference only and the information may be out of date.

Cover of GeneReviews®

GeneReviews® [Internet].

Show details

Table 3.

Serum CK Concentration and Muscle Biopsy Findings in the Congenital Muscular Dystrophies Discussed in Table 1

DisorderSerum CK
Concentration 1
Muscle Biopsy
HistologyImmunohistochemistry
Defects of structural protein
Laminin alpha-2 deficiency (MDC1A)Variable CK from mildly elevated to markedly elevated (before muscle wasting is severe)Neonatal: myopathic or dystrophic w/or w/out inflammatory changes
  • Merosin: partial or total deficiency 2
  • Laminin alpha-5: overexpression
End stage: dystrophic changes
Collagen VI-deficient CMDNormal or mildly elevated (~2-3x normal)Fiber size variationCollagen VI:
  • Variable reduction in muscle
  • Abnormal secretion in fibroblast culture
  • Deficiency difficult to detect if partial 3
Variable necrotic or regenerative fibers
Variable endomysial fibrosis
Defects of glycosylation
DystroglycanopathiesElevated: 2-15x normalMyopathic or dystrophic
  • Merosin: normal or reduced
  • Glycosylated alpha dystroglycan: deficient
  • Beta dystroglycan: normal
Defects of proteins of the endoplasmic reticulum
SELENON (SEPN1)-related CMDNormalVariable fiber sizeMerosin & collagen VI: normal
Occasional necrotic fibers
Minimally increased endomysial connective tissue
Defects of nuclear envelope proteins
L-CMD2-5x normalDystrophic changes (deltoid> quadriceps)
  • Merosin: normal
  • Alpha-dystroglycan: possible secondary abnormal expression
Nonspecific myopathic changes (quadriceps)
Markedly atrophic fibers, most often type 1, occasional positive inflammatory markers
1.

Normal serum CK concentration = 35-160 µ/L (may vary slightly in different laboratories)

2.

Ideally using antibodies recognizing different regions of the protein

3.

May need co-staining with merosin, perlecan, or other proteins to demonstrate abnormal sarcolemmal staining of collagen VI

From: Congenital Muscular Dystrophy Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY

Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

Views

  • Cite this Page
  • PDF version of this page (538K)

Similar articles in PubMed

See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...